Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
339M
-
Number of holders
-
103
-
Total 13F shares, excl. options
-
155M
-
Shares change
-
+2.64M
-
Total reported value, excl. options
-
$1.32B
-
Value change
-
+$21M
-
Number of buys
-
60
-
Number of sells
-
-36
-
Price
-
$8.50
Significant Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q4 2021
115 filings reported holding NUVB - Nuvation Bio Inc. - Common Stock as of Q4 2021.
Nuvation Bio Inc. - Common Stock (NUVB) has 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 155M shares
of 339M outstanding shares and own 45.77% of the company stock.
Largest 10 shareholders include FMR LLC (31.7M shares), Omega Fund Management, LLC (23M shares), EcoR1 Capital, LLC (13.9M shares), VANGUARD GROUP INC (11.3M shares), BlackRock Inc. (10.8M shares), BAUPOST GROUP LLC/MA (8.62M shares), Avidity Partners Management LP (7.38M shares), CITADEL ADVISORS LLC (5.5M shares), BOXER CAPITAL, LLC (4.34M shares), and ABRAMS CAPITAL MANAGEMENT, L.P. (3.81M shares).
This table shows the top 103 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.